UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 811

Sortiert nach

Remnant Cholesterol and Atherosclerotic Cardiovascular Disease Risk

Journal of the American College of Cardiology, 2020-12, Vol.76 (23), p.2736-2739

2020

Link zum Volltext

Verfügbarkeit prüfen

HDL Particle Size Is a Critical Determinant of ABCA1-Mediated Macrophage Cellular Cholesterol Export

Circulation research, 2015-03, Vol.116 (7), p.1133-1142

2015

Link zum Volltext

Verfügbarkeit prüfen

Effect of Lipoprotein(a) on the Diagnosis of Familial Hypercholesterolemia: Does It Make a Difference in the Clinic?

Clinical chemistry (Baltimore, Md.), 2019-10, Vol.65 (10), p.1258-1266

2019

Link zum Volltext

Verfügbarkeit prüfen

Contemporary Aspects of the Biology and Therapeutic Regulation of the Microsomal Triglyceride Transfer Protein

Circulation research, 2015-01, Vol.116 (1), p.193-205

2015

Link zum Volltext

Verfügbarkeit prüfen

A Comparative Analysis of Phenotypic Predictors of Mutations in Familial Hypercholesterolemia

The journal of clinical endocrinology and metabolism, 2018-04, Vol.103 (4), p.1704-1714

2018

Link zum Volltext

Verfügbarkeit prüfen

The C679X mutation in PCSK9 is present and lowers blood cholesterol in a Southern African population

Atherosclerosis, 2007-08, Vol.193 (2), p.445-448

2007

Link zum Volltext

Verfügbarkeit prüfen

The role of patient registries for rare genetic lipid disorders

Current opinion in lipidology, 2018-04, Vol.29 (2), p.156-162

2018

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: An Australian experience

Atherosclerosis, 2015-03, Vol.239 (1), p.93-100

2015

Link zum Volltext

Verfügbarkeit prüfen

Progress in the care of common inherited atherogenic disorders of apolipoprotein B metabolism

Nature reviews. Endocrinology, 2016-08, Vol.12 (8), p.467

2016

Link zum Volltext

Verfügbarkeit prüfen

Familial combined hyperlipidemia and hyperlipoprotein(a) as phenotypic mimics of familial hypercholesterolemia: Frequencies, associations and predictions

Journal of clinical lipidology, 2016-11, Vol.10 (6), p.1329-1337.e3

2016

Link zum Volltext

Verfügbarkeit prüfen

Pathology: evolution not revolution

Pathology, 2024-04, Vol.56 (3), p.298-299

Burnett, John R.

2024

Link zum Volltext

Verfügbarkeit prüfen

Elevated lipoprotein(a) and familial hypercholesterolemia in the coronary care unit: Between Scylla and Charybdis

Clinical cardiology (Mahwah, N.J.), 2018-03, Vol.41 (3), p.378-384

2018

Link zum Volltext

Verfügbarkeit prüfen

Genetic analysis of familial hypercholesterolaemia in Western Australia

Atherosclerosis, 2012-10, Vol.224 (2), p.430-434

2012

Link zum Volltext

Verfügbarkeit prüfen

Elevated Plasma PCSK9 Level Is Equally Detrimental for Patients With Nonfamilial Hypercholesterolemia and Heterozygous Familial Hypercholesterolemia, Irrespective of Low-Density Lipoprotein Receptor Defects

Journal of the American College of Cardiology, 2014-06, Vol.63 (22), p.2365-2373

2014

Link zum Volltext

Verfügbarkeit prüfen

Clinical utility gene card for: Familial hypobetalipoproteinaemia (APOB)--Update 2014

European journal of human genetics : EJHG, 2015-06, Vol.23 (6), p.889-889

2015

Link zum Volltext

Verfügbarkeit prüfen

Lipid Disorders and Mutations in the APOB Gene

Clinical chemistry (Baltimore, Md.), 2004-10, Vol.50 (10), p.1725-1732

2004

Link zum Volltext

Verfügbarkeit prüfen

Lipoprotein apheresis and new therapies for severe familial hypercholesterolemia in adults and children

Best Practice & Research Clinical Endocrinology & Metabolism, 2014-06, Vol.28 (3), p.387-403

2014

Link zum Volltext

Verfügbarkeit prüfen

Update on the diagnosis, treatment and management of rare genetic lipid disorders

Pathology, 2019-02, Vol.51 (2), p.193-201

2019

Link zum Volltext

Verfügbarkeit prüfen

Detecting familial hypercholesterolaemia in the community: Impact of a telephone call from a chemical pathologist to the requesting general practitioner

Atherosclerosis, 2014-06, Vol.234 (2), p.469-472

2014

Link zum Volltext

Verfügbarkeit prüfen

Opportunistic screening for familial hypercholesterolaemia via a community laboratory

Annals of clinical biochemistry, 2012-11, Vol.49 (Pt 6), p.534

2012

Link zum Volltext

Verfügbarkeit prüfen

Clinical utility gene card for: Tangier disease

European journal of human genetics : EJHG, 2017-06, Vol.25 (7), p.e1-e3

2017

Link zum Volltext

Verfügbarkeit prüfen

Anacetrapib for the treatment of dyslipidaemia: the last bastion of the cholesteryl ester transfer protein inhibitors?

Expert opinion on pharmacotherapy, 2016-01, Vol.17 (2), p.275-281

2016

Link zum Volltext

Verfügbarkeit prüfen

Non-HDL-cholesterol and apolipoprotein B compared with LDL-cholesterol in atherosclerotic cardiovascular disease risk assessment

Pathology, 2019-02, Vol.51 (2), p.148-154

2019

Link zum Volltext

Verfügbarkeit prüfen

Impact of interpretative commenting on lipid profiles in people at high risk of familial hypercholesterolaemia

Clinica chimica acta, 2013-06, Vol.422, p.21-25

2013

Link zum Volltext

Verfügbarkeit prüfen

MK-0616: an oral PCSK9 inhibitor for hypercholesterolemia treatment

Expert opinion on investigational drugs, 2023-10, Vol.32 (10), p.873-878

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 811

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(723)
Mit Volltextzugriff
(717)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(536)
Life Sciences & Biomedicine
(479)
Humans
(392)
Male
(231)
Female
(208)
Biological And Medical Sciences
(191)
Medical Sciences
(163)
Middle Aged
(154)
Animals
(128)
Adult
(121)
Cardiovascular System & Cardiology
(120)
Aged
(116)
Cardiac & Cardiovascular Systems
(95)
Peripheral Vascular Disease
(59)
Cardiology. Vascular System
(53)
Risk Factors
(50)
General & Internal Medicine
(48)
Cardiovascular Disease
(45)
Heart
(44)
Medicine, General & Internal
(43)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Remnant Cholesterol and Atherosclerotic Cardiovascular Disease Risk

HDL Particle Size Is a Critical Determinant of ABCA1-Mediated Macrophage Cellular Cholesterol Export

Effect of Lipoprotein(a) on the Diagnosis of Familial Hypercholesterolemia: Does It Make a Difference in the Clinic?

Contemporary Aspects of the Biology and Therapeutic Regulation of the Microsomal Triglyceride Transfer Protein

A Comparative Analysis of Phenotypic Predictors of Mutations in Familial Hypercholesterolemia

The C679X mutation in PCSK9 is present and lowers blood cholesterol in a Southern African population

The role of patient registries for rare genetic lipid disorders

Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: An Australian experience

Progress in the care of common inherited atherogenic disorders of apolipoprotein B metabolism

Familial combined hyperlipidemia and hyperlipoprotein(a) as phenotypic mimics of familial hypercholesterolemia: Frequencies, associations and predictions

Pathology: evolution not revolution

Elevated lipoprotein(a) and familial hypercholesterolemia in the coronary care unit: Between Scylla and Charybdis

Genetic analysis of familial hypercholesterolaemia in Western Australia

Elevated Plasma PCSK9 Level Is Equally Detrimental for Patients With Nonfamilial Hypercholesterolemia and Heterozygous Familial Hypercholesterolemia, Irrespective of Low-Density Lipoprotein Receptor Defects

Clinical utility gene card for: Familial hypobetalipoproteinaemia (APOB)--Update 2014

Lipid Disorders and Mutations in the APOB Gene

Lipoprotein apheresis and new therapies for severe familial hypercholesterolemia in adults and children

Update on the diagnosis, treatment and management of rare genetic lipid disorders

Detecting familial hypercholesterolaemia in the community: Impact of a telephone call from a chemical pathologist to the requesting general practitioner

Opportunistic screening for familial hypercholesterolaemia via a community laboratory

Clinical utility gene card for: Tangier disease

Anacetrapib for the treatment of dyslipidaemia: the last bastion of the cholesteryl ester transfer protein inhibitors?

Non-HDL-cholesterol and apolipoprotein B compared with LDL-cholesterol in atherosclerotic cardiovascular disease risk assessment

Impact of interpretative commenting on lipid profiles in people at high risk of familial hypercholesterolaemia

MK-0616: an oral PCSK9 inhibitor for hypercholesterolemia treatment

Suchergebnisse filtern